Corporate Governance
The Board of Directors of Eurand Pharmaceuticals (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
| Documents | View | ||
|---|---|---|---|
| Articles of Association |
2.3 MB
|
||
| Corporate Governance Guidelines |
42.3 KB
|
||
| Code of Business Conduct and Ethics |
277.0 KB
|
||
| Insider Trading Policy |
111.0 KB
|
||
| Audit Committee Charter |
59.7 KB
|
||
| Compensation Committee Charter |
39.0 KB
|
||
| Nominating and Corporate Governance Committee Charter |
37.1 KB
|
||
| Whistleblowing Policy |
87.9 KB
|
||
| Eurand Compensation Policy |
32.1 KB
|
||
| Profile of the Board of Directors |
20.3 KB
|
||
Stock Information
| Ticker | EURX |
| Exchange | NASDAQ |
| Price | $11.05 |
| Change | - 0.01 |
| Volume | 69,900 |
| Mar 12, 2010 - 4:00 PM ET | |
